We have more than 80 years experience in the field of complex and high value generic pharmaceutical products.


The safety and effectiveness of our pharmaceutical products are our symbol of quality.


Our production plant and quality control and development laboratories have the most advanced technologies.

TRIVENZ®: Exclusive development for HIV

Laboratorios Richmond has announced the launch of TRIVENZ®, the first generic in Argentina with the combination of Efavirenz, Emtricitabine and Tenofovir DF. This product for HIV treatment required the exclusive development of a monolithic tablet to ensure physic-chemical compatibility and bioavailability of the active ingredients.


Read more +

Richmond certificates IRAM - ISO 14001:2005

Reaffirming the commitment to the environment and the community, Laboratorios Richmond obtained its ISO 14001 certification, consolidating its environmental management system under the highest international quality standards.

Read more +

The Professional Practices arrived to Laboratorios Richmond

Portada Practicas profesionalizantes

With the objective of contributing to the professional growth of young people and helping them to integrate into the working world successfully, Laboratorios Richmond adhered to the program that the Municipality of Pilar carries out with students, teachers and authorities of the Technical Schools.

Antituberculosis drug developed by CONICET together with Richmond also receives patent in Europe.


The new TB antimicrobial, developed by researchers and fellows of CONICET together with Laboratorios Richmond, obtained last February the Patent in the US and now received another of the European Patent Office (EPO).

Richmond invests in Colombia

Richmond invierte en Colombia

Laboratorios Richmond signed an investment agreement with Colombian Laboratorios Expofarma, with the objective of increasing and developing present operations both in Colombia and other markets where both companies currently commercialize their line of products.